Quick Summary
Additional Context
3D printing medicines has often been tied to the idea of personalization, basically making a pill in the right dose, shape, or drug combination for a patient. PharmaTher is now trying to build something much larger around that capability.
The Canadian pharmaceutical company has launched its M3DICINES National Network Program, a plan to create a distributed network of sites that can 3D print medicines closer to where they are needed. The program will begin with U.S. compounding pharmacies and could eventually extend to hospitals, contract manufacturers, research institutions, and government facilities.
Instead of producing every medicine at a central plant and shipping finished doses around the country, PharmaTher’s model would distribute validated formulations and digital manufacturing i